Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Joseph Markowitz

10PUBLICATIONS
43CO-AUTHORS
Tumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Formal methods for softwareMechanobiologyMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

Sort by Publication Date:
|Jan 14, 2026
Neoadjuvant lenvatinib plus pembrolizumab in Merkel cell carcinoma: an investigator-initiated, open-label phase II trial.

Andrew S Brohl, Vernon K Sondak, Evan J Wuthrick

|Mar 06, 2025
Phase II Trial of Pembrolizumab in Combination With Bevacizumab for Untreated Melanoma Brain Metastases.

Sarah A Weiss, Dijana Djureinovic, Wei Wei

|Dec 05, 2024
spatialGE Is a User-Friendly Web Application That Facilitates Spatial Transcriptomics Data Analysis.

Oscar E Ospina, Roberto Manjarres-Betancur, Guillermo Gonzalez-Calderon

|Sep 06, 2024
Durability of response to immune checkpoint blockade following treatment discontinuation and efficacy of rechallenge in advanced Merkel cell carcinoma.

Tanya Ramadoss, Matthew Nichols, Christian Palacios

|Jul 15, 2024
spatialGE: A user-friendly web application to democratize spatial transcriptomics analysis.

Oscar E Ospina, Roberto Manjarres-Betancur, Guillermo Gonzalez-Calderon

|Apr 24, 2024
First-in-Human Stage III/IV Melanoma Clinical Trial of Immune Priming Agent IFx-Hu2.0.

Joseph Markowitz, Michael Shamblott, Andrew S Brohl

Pageof 2

Frequent Collaborators

4 joint publications

Zeynep Eroglu

4 joint publications

Nikhil I Khushalani

3 joint publications

Andrew S Brohl

3 joint publications

Kenneth Y Tsai

3 joint publications

Ahmad A Tarhini

2 joint publications

Inna Smalley

2 joint publications

Alex C Soupir

2 joint publications

Ethan Vallebuona

2 joint publications

Amod Sarnaik

2 joint publications

Oscar E Ospina

Frequent Collaborators

4 joint publications

Zeynep Eroglu

4 joint publications

Nikhil I Khushalani

3 joint publications

Andrew S Brohl

3 joint publications

Kenneth Y Tsai

Top Related Videos

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients
07:43

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients

Published on : Sep 25, 2018

11.0K
Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on : Oct 27, 2014

27.0K
Methods to Enable Spatial Transcriptomics of Bone Tissues
07:43

Methods to Enable Spatial Transcriptomics of Bone Tissues

Published on : May 03, 2024

2.5K
See more related videos

Top Related Videos

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients
07:43

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients

Published on : Sep 25, 2018

11.0K
Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on : Oct 27, 2014

27.0K
Methods to Enable Spatial Transcriptomics of Bone Tissues
07:43

Methods to Enable Spatial Transcriptomics of Bone Tissues

Published on : May 03, 2024

2.5K
See more related videos